Global Generic Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global Generic Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Generic Drugs
1.2 Classification of Generic Drugs by Type
1.2.1 Overview: Global Generic Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Generic Drugs Revenue Market Share by Type in 2020
1.2.3 Prescription
1.2.4 Non-Prescription Drugs
1.3 Global Generic Drugs Market by Application
1.3.1 Overview: Global Generic Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Generic Drugs Market Size & Forecast
1.5 Global Generic Drugs Market Size and Forecast by Region
1.5.1 Global Generic Drugs Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Generic Drugs Market Size by Region, (2016-2021)
1.5.3 North America Generic Drugs Market Size and Prospect (2016-2026)
1.5.4 Europe Generic Drugs Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Generic Drugs Market Size and Prospect (2016-2026)
1.5.6 South America Generic Drugs Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Generic Drugs Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Generic Drugs Market Drivers
1.6.2 Generic Drugs Market Restraints
1.6.3 Generic Drugs Trends Analysis
2 Company Profiles
2.1 Teva
2.1.1 Teva Details
2.1.2 Teva Major Business
2.1.3 Teva Generic Drugs Product and Solutions
2.1.4 Teva Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Teva Recent Developments and Future Plans
2.2 Novartis - Sandoz
2.2.1 Novartis - Sandoz Details
2.2.2 Novartis - Sandoz Major Business
2.2.3 Novartis - Sandoz Generic Drugs Product and Solutions
2.2.4 Novartis - Sandoz Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis - Sandoz Recent Developments and Future Plans
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Generic Drugs Product and Solutions
2.3.4 Mylan Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Mylan Recent Developments and Future Plans
2.4 Sun Pharmaceutical
2.4.1 Sun Pharmaceutical Details
2.4.2 Sun Pharmaceutical Major Business
2.4.3 Sun Pharmaceutical Generic Drugs Product and Solutions
2.4.4 Sun Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Sun Pharmaceutical Recent Developments and Future Plans
2.5 Aspen
2.5.1 Aspen Details
2.5.2 Aspen Major Business
2.5.3 Aspen Generic Drugs Product and Solutions
2.5.4 Aspen Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Aspen Recent Developments and Future Plans
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business
2.6.3 Fresenius Kabi Generic Drugs Product and Solutions
2.6.4 Fresenius Kabi Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Fresenius Kabi Recent Developments and Future Plans
2.7 Pfizer (Hospira)
2.7.1 Pfizer (Hospira) Details
2.7.2 Pfizer (Hospira) Major Business
2.7.3 Pfizer (Hospira) Generic Drugs Product and Solutions
2.7.4 Pfizer (Hospira) Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Pfizer (Hospira) Recent Developments and Future Plans
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Generic Drugs Product and Solutions
2.8.4 Sanofi Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Sanofi Recent Developments and Future Plans
2.9 Aurobindo
2.9.1 Aurobindo Details
2.9.2 Aurobindo Major Business
2.9.3 Aurobindo Generic Drugs Product and Solutions
2.9.4 Aurobindo Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Aurobindo Recent Developments and Future Plans
2.10 Lupin
2.10.1 Lupin Details
2.10.2 Lupin Major Business
2.10.3 Lupin Generic Drugs Product and Solutions
2.10.4 Lupin Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Lupin Recent Developments and Future Plans
2.11 Dr. Reddy's
2.11.1 Dr. Reddy's Details
2.11.2 Dr. Reddy's Major Business
2.11.3 Dr. Reddy's Generic Drugs Product and Solutions
2.11.4 Dr. Reddy's Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Dr. Reddy's Recent Developments and Future Plans
2.12 Apotex
2.12.1 Apotex Details
2.12.2 Apotex Major Business
2.12.3 Apotex Generic Drugs Product and Solutions
2.12.4 Apotex Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Apotex Recent Developments and Future Plans
2.13 Cipla
2.13.1 Cipla Details
2.13.2 Cipla Major Business
2.13.3 Cipla Generic Drugs Product and Solutions
2.13.4 Cipla Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Cipla Recent Developments and Future Plans
2.14 ENDO (Par Pharmaceutical)
2.14.1 ENDO (Par Pharmaceutical) Details
2.14.2 ENDO (Par Pharmaceutical) Major Business
2.14.3 ENDO (Par Pharmaceutical) Generic Drugs Product and Solutions
2.14.4 ENDO (Par Pharmaceutical) Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 ENDO (Par Pharmaceutical) Recent Developments and Future Plans
2.15 Stada Arzneimittel
2.15.1 Stada Arzneimittel Details
2.15.2 Stada Arzneimittel Major Business
2.15.3 Stada Arzneimittel Generic Drugs Product and Solutions
2.15.4 Stada Arzneimittel Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Stada Arzneimittel Recent Developments and Future Plans
2.16 Krka Group
2.16.1 Krka Group Details
2.16.2 Krka Group Major Business
2.16.3 Krka Group Generic Drugs Product and Solutions
2.16.4 Krka Group Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Krka Group Recent Developments and Future Plans
2.17 Nichi-Iko Pharmaceutical
2.17.1 Nichi-Iko Pharmaceutical Details
2.17.2 Nichi-Iko Pharmaceutical Major Business
2.17.3 Nichi-Iko Pharmaceutical Generic Drugs Product and Solutions
2.17.4 Nichi-Iko Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 Nichi-Iko Pharmaceutical Recent Developments and Future Plans
2.18 Valeant
2.18.1 Valeant Details
2.18.2 Valeant Major Business
2.18.3 Valeant Generic Drugs Product and Solutions
2.18.4 Valeant Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 Valeant Recent Developments and Future Plans
2.19 Zydus Cadila
2.19.1 Zydus Cadila Details
2.19.2 Zydus Cadila Major Business
2.19.3 Zydus Cadila Generic Drugs Product and Solutions
2.19.4 Zydus Cadila Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Zydus Cadila Recent Developments and Future Plans
2.20 Hikma
2.20.1 Hikma Details
2.20.2 Hikma Major Business
2.20.3 Hikma Generic Drugs Product and Solutions
2.20.4 Hikma Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Hikma Recent Developments and Future Plans
2.21 Pharmaniaga Berhad
2.21.1 Pharmaniaga Berhad Details
2.21.2 Pharmaniaga Berhad Major Business
2.21.3 Pharmaniaga Berhad Generic Drugs Product and Solutions
2.21.4 Pharmaniaga Berhad Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.21.5 Pharmaniaga Berhad Recent Developments and Future Plans
2.22 Hovid Berhad
2.22.1 Hovid Berhad Details
2.22.2 Hovid Berhad Major Business
2.22.3 Hovid Berhad Generic Drugs Product and Solutions
2.22.4 Hovid Berhad Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.22.5 Hovid Berhad Recent Developments and Future Plans
2.23 Duopharma Biotech
2.23.1 Duopharma Biotech Details
2.23.2 Duopharma Biotech Major Business
2.23.3 Duopharma Biotech Generic Drugs Product and Solutions
2.23.4 Duopharma Biotech Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.23.5 Duopharma Biotech Recent Developments and Future Plans
2.24 Kotra Pharma
2.24.1 Kotra Pharma Details
2.24.2 Kotra Pharma Major Business
2.24.3 Kotra Pharma Generic Drugs Product and Solutions
2.24.4 Kotra Pharma Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.24.5 Kotra Pharma Recent Developments and Future Plans
2.25 HOE Pharmaceutical
2.25.1 HOE Pharmaceutical Details
2.25.2 HOE Pharmaceutical Major Business
2.25.3 HOE Pharmaceutical Generic Drugs Product and Solutions
2.25.4 HOE Pharmaceutical Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.25.5 HOE Pharmaceutical Recent Developments and Future Plans
2.26 Y.S.P. Industries
2.26.1 Y.S.P. Industries Details
2.26.2 Y.S.P. Industries Major Business
2.26.3 Y.S.P. Industries Generic Drugs Product and Solutions
2.26.4 Y.S.P. Industries Generic Drugs Revenue, Gross Margin and Market Share (2019-2021)
2.26.5 Y.S.P. Industries Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Generic Drugs Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Generic Drugs Players Market Share
3.2.2 Top 10 Generic Drugs Players Market Share
3.2.3 Market Competition Trend
3.3 Generic Drugs Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Generic Drugs Revenue and Market Share by Type (2016-2021)
4.2 Global Generic Drugs Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Generic Drugs Revenue Market Share by Application (2016-2021)
5.2 Generic Drugs Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Generic Drugs Revenue by Type (2016-2026)
6.2 North America Generic Drugs Revenue by Application (2016-2026)
6.3 North America Generic Drugs Market Size by Country
6.3.1 North America Generic Drugs Revenue by Country (2016-2026)
6.3.2 United States Generic Drugs Market Size and Forecast (2016-2026)
6.3.3 Canada Generic Drugs Market Size and Forecast (2016-2026)
6.3.4 Mexico Generic Drugs Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Generic Drugs Revenue by Type (2016-2026)
7.2 Europe Generic Drugs Revenue by Application (2016-2026)
7.3 Europe Generic Drugs Market Size by Country
7.3.1 Europe Generic Drugs Revenue by Country (2016-2026)
7.3.2 Germany Generic Drugs Market Size and Forecast (2016-2026)
7.3.3 France Generic Drugs Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Generic Drugs Market Size and Forecast (2016-2026)
7.3.5 Russia Generic Drugs Market Size and Forecast (2016-2026)
7.3.6 Italy Generic Drugs Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Generic Drugs Revenue by Type (2016-2026)
8.2 Asia-Pacific Generic Drugs Revenue by Application (2016-2026)
8.3 Asia-Pacific Generic Drugs Market Size by Region
8.3.1 Asia-Pacific Generic Drugs Revenue by Region (2016-2026)
8.3.2 China Generic Drugs Market Size and Forecast (2016-2026)
8.3.3 Japan Generic Drugs Market Size and Forecast (2016-2026)
8.3.4 South Korea Generic Drugs Market Size and Forecast (2016-2026)
8.3.5 India Generic Drugs Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Generic Drugs Market Size and Forecast (2016-2026)
8.3.7 Australia Generic Drugs Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Generic Drugs Revenue by Type (2016-2026)
9.2 South America Generic Drugs Revenue by Application (2016-2026)
9.3 South America Generic Drugs Market Size by Country
9.3.1 South America Generic Drugs Revenue by Country (2016-2026)
9.3.2 Brazil Generic Drugs Market Size and Forecast (2016-2026)
9.3.3 Argentina Generic Drugs Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Generic Drugs Revenue by Type (2016-2026)
10.2 Middle East & Africa Generic Drugs Revenue by Application (2016-2026)
10.3 Middle East & Africa Generic Drugs Market Size by Country
10.3.1 Middle East & Africa Generic Drugs Revenue by Country (2016-2026)
10.3.2 Turkey Generic Drugs Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Generic Drugs Market Size and Forecast (2016-2026)
10.3.4 UAE Generic Drugs Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Generic Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Generic Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Generic Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Generic Drugs Revenue (USD Million) by Region (2016-2021)
Table 5. Global Generic Drugs Revenue Market Share by Region (2021-2026)
Table 6. Teva Corporate Information, Head Office, and Major Competitors
Table 7. Teva Major Business
Table 8. Teva Generic Drugs Product and Solutions
Table 9. Teva Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis - Sandoz Corporate Information, Head Office, and Major Competitors
Table 11. Novartis - Sandoz Major Business
Table 12. Novartis - Sandoz Generic Drugs Product and Solutions
Table 13. Novartis - Sandoz Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Mylan Corporate Information, Head Office, and Major Competitors
Table 15. Mylan Major Business
Table 16. Mylan Generic Drugs Product and Solutions
Table 17. Mylan Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 19. Sun Pharmaceutical Major Business
Table 20. Sun Pharmaceutical Generic Drugs Product and Solutions
Table 21. Sun Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Aspen Corporate Information, Head Office, and Major Competitors
Table 23. Aspen Major Business
Table 24. Aspen Generic Drugs Product and Solutions
Table 25. Aspen Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Fresenius Kabi Corporate Information, Head Office, and Major Competitors
Table 27. Fresenius Kabi Major Business
Table 28. Fresenius Kabi Generic Drugs Product and Solutions
Table 29. Fresenius Kabi Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Pfizer (Hospira) Corporate Information, Head Office, and Major Competitors
Table 31. Pfizer (Hospira) Major Business
Table 32. Pfizer (Hospira) Generic Drugs Product and Solutions
Table 33. Pfizer (Hospira) Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Sanofi Corporate Information, Head Office, and Major Competitors
Table 35. Sanofi Major Business
Table 36. Sanofi Generic Drugs Product and Solutions
Table 37. Sanofi Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Aurobindo Corporate Information, Head Office, and Major Competitors
Table 39. Aurobindo Major Business
Table 40. Aurobindo Generic Drugs Product and Solutions
Table 41. Aurobindo Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Lupin Corporate Information, Head Office, and Major Competitors
Table 43. Lupin Major Business
Table 44. Lupin Generic Drugs Product and Solutions
Table 45. Lupin Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Dr. Reddy's Corporate Information, Head Office, and Major Competitors
Table 47. Dr. Reddy's Major Business
Table 48. Dr. Reddy's Generic Drugs Product and Solutions
Table 49. Dr. Reddy's Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Apotex Corporate Information, Head Office, and Major Competitors
Table 51. Apotex Major Business
Table 52. Apotex Generic Drugs Product and Solutions
Table 53. Apotex Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Cipla Corporate Information, Head Office, and Major Competitors
Table 55. Cipla Major Business
Table 56. Cipla Generic Drugs Product and Solutions
Table 57. Cipla Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. ENDO (Par Pharmaceutical) Corporate Information, Head Office, and Major Competitors
Table 59. ENDO (Par Pharmaceutical) Major Business
Table 60. ENDO (Par Pharmaceutical) Generic Drugs Product and Solutions
Table 61. ENDO (Par Pharmaceutical) Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Stada Arzneimittel Corporate Information, Head Office, and Major Competitors
Table 63. Stada Arzneimittel Major Business
Table 64. Stada Arzneimittel Generic Drugs Product and Solutions
Table 65. Stada Arzneimittel Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Krka Group Corporate Information, Head Office, and Major Competitors
Table 67. Krka Group Major Business
Table 68. Krka Group Generic Drugs Product and Solutions
Table 69. Krka Group Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. Nichi-Iko Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 71. Nichi-Iko Pharmaceutical Major Business
Table 72. Nichi-Iko Pharmaceutical Generic Drugs Product and Solutions
Table 73. Nichi-Iko Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Valeant Corporate Information, Head Office, and Major Competitors
Table 75. Valeant Major Business
Table 76. Valeant Generic Drugs Product and Solutions
Table 77. Valeant Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Zydus Cadila Corporate Information, Head Office, and Major Competitors
Table 79. Zydus Cadila Major Business
Table 80. Zydus Cadila Generic Drugs Product and Solutions
Table 81. Zydus Cadila Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Hikma Corporate Information, Head Office, and Major Competitors
Table 83. Hikma Major Business
Table 84. Hikma Generic Drugs Product and Solutions
Table 85. Hikma Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Pharmaniaga Berhad Corporate Information, Head Office, and Major Competitors
Table 87. Pharmaniaga Berhad Major Business
Table 88. Pharmaniaga Berhad Generic Drugs Product and Solutions
Table 89. Pharmaniaga Berhad Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 90. Hovid Berhad Corporate Information, Head Office, and Major Competitors
Table 91. Hovid Berhad Major Business
Table 92. Hovid Berhad Generic Drugs Product and Solutions
Table 93. Hovid Berhad Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 94. Duopharma Biotech Corporate Information, Head Office, and Major Competitors
Table 95. Duopharma Biotech Major Business
Table 96. Duopharma Biotech Generic Drugs Product and Solutions
Table 97. Duopharma Biotech Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 98. Kotra Pharma Corporate Information, Head Office, and Major Competitors
Table 99. Kotra Pharma Major Business
Table 100. Kotra Pharma Generic Drugs Product and Solutions
Table 101. Kotra Pharma Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 102. HOE Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 103. HOE Pharmaceutical Major Business
Table 104. HOE Pharmaceutical Generic Drugs Product and Solutions
Table 105. HOE Pharmaceutical Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 106. Y.S.P. Industries Corporate Information, Head Office, and Major Competitors
Table 107. Y.S.P. Industries Major Business
Table 108. Y.S.P. Industries Generic Drugs Product and Solutions
Table 109. Y.S.P. Industries Generic Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 110. Global Generic Drugs Revenue (USD Million) by Players (2019-2021)
Table 111. Global Generic Drugs Revenue Share by Players (2019-2021)
Table 112. Breakdown of Generic Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 113. Generic Drugs Players Head Office, Products and Services Provided
Table 114. Generic Drugs Mergers & Acquisitions in the Past Five Years
Table 115. Generic Drugs New Entrants and Expansion Plans
Table 116. Global Generic Drugs Revenue (USD Million) by Type (2016-2021)
Table 117. Global Generic Drugs Revenue Share by Type (2016-2021)
Table 118. Global Generic Drugs Revenue Forecast by Type (2021-2026)
Table 119. Global Generic Drugs Revenue by Application (2016-2021)
Table 120. Global Generic Drugs Revenue Forecast by Application (2021-2026)
Table 121. North America Generic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 122. North America Generic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 123. North America Generic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 124. North America Generic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 125. North America Generic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 126. North America Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 127. Europe Generic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 128. Europe Generic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 129. Europe Generic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 130. Europe Generic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 131. Europe Generic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 132. Europe Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 133. Asia-Pacific Generic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 134. Asia-Pacific Generic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 135. Asia-Pacific Generic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 136. Asia-Pacific Generic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 137. Asia-Pacific Generic Drugs Revenue by Region (2016-2021) & (USD Million)
Table 138. Asia-Pacific Generic Drugs Revenue by Region (2021-2026) & (USD Million)
Table 139. South America Generic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 140. South America Generic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 141. South America Generic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 142. South America Generic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 143. South America Generic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 144. South America Generic Drugs Revenue by Country (2021-2026) & (USD Million)
Table 145. Middle East & Africa Generic Drugs Revenue by Type (2016-2021) & (USD Million)
Table 146. Middle East & Africa Generic Drugs Revenue by Type (2021-2026) & (USD Million)
Table 147. Middle East & Africa Generic Drugs Revenue by Application (2016-2021) & (USD Million)
Table 148. Middle East & Africa Generic Drugs Revenue by Application (2021-2026) & (USD Million)
Table 149. Middle East & Africa Generic Drugs Revenue by Country (2016-2021) & (USD Million)
Table 150. Middle East & Africa Generic Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Generic Drugs Picture
Figure 2. Global Generic Drugs Revenue Market Share by Type in 2020
Figure 3. Prescription
Figure 4. Non-Prescription Drugs
Figure 5. Generic Drugs Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Others Picture
Figure 9. Global Generic Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Generic Drugs Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Generic Drugs Revenue Market Share by Region (2016-2026)
Figure 12. Global Generic Drugs Revenue Market Share by Region in 2020
Figure 13. North America Generic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Generic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Generic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Generic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Generic Drugs Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Generic Drugs Market Drivers
Figure 19. Generic Drugs Market Restraints
Figure 20. Generic Drugs Market Trends
Figure 21. Teva Recent Developments and Future Plans
Figure 22. Novartis - Sandoz Recent Developments and Future Plans
Figure 23. Mylan Recent Developments and Future Plans
Figure 24. Sun Pharmaceutical Recent Developments and Future Plans
Figure 25. Aspen Recent Developments and Future Plans
Figure 26. Fresenius Kabi Recent Developments and Future Plans
Figure 27. Pfizer (Hospira) Recent Developments and Future Plans
Figure 28. Sanofi Recent Developments and Future Plans
Figure 29. Aurobindo Recent Developments and Future Plans
Figure 30. Lupin Recent Developments and Future Plans
Figure 31. Dr. Reddy's Recent Developments and Future Plans
Figure 32. Apotex Recent Developments and Future Plans
Figure 33. Cipla Recent Developments and Future Plans
Figure 34. ENDO (Par Pharmaceutical) Recent Developments and Future Plans
Figure 35. Stada Arzneimittel Recent Developments and Future Plans
Figure 36. Krka Group Recent Developments and Future Plans
Figure 37. Nichi-Iko Pharmaceutical Recent Developments and Future Plans
Figure 38. Valeant Recent Developments and Future Plans
Figure 39. Zydus Cadila Recent Developments and Future Plans
Figure 40. Hikma Recent Developments and Future Plans
Figure 41. Pharmaniaga Berhad Recent Developments and Future Plans
Figure 42. Hovid Berhad Recent Developments and Future Plans
Figure 43. Duopharma Biotech Recent Developments and Future Plans
Figure 44. Kotra Pharma Recent Developments and Future Plans
Figure 45. HOE Pharmaceutical Recent Developments and Future Plans
Figure 46. Y.S.P. Industries Recent Developments and Future Plans
Figure 47. Global Generic Drugs Revenue Share by Players in 2020
Figure 48. Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 49. Global Top 3 Players Generic Drugs Revenue Market Share in 2020
Figure 50. Global Top 10 Players Generic Drugs Revenue Market Share in 2020
Figure 51. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 52. Global Generic Drugs Revenue Share by Type in 2020
Figure 53. Global Generic Drugs Market Share Forecast by Type (2021-2026)
Figure 54. Global Generic Drugs Revenue Share by Application in 2020
Figure 55. Global Generic Drugs Market Share Forecast by Application (2021-2026)
Figure 56. North America Generic Drugs Sales Market Share by Type (2016-2026)
Figure 57. North America Generic Drugs Sales Market Share by Application (2016-2026)
Figure 58. North America Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 59. United States Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Canada Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Mexico Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Europe Generic Drugs Sales Market Share by Type (2016-2026)
Figure 63. Europe Generic Drugs Sales Market Share by Application (2016-2026)
Figure 64. Europe Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 65. Germany Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. France Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. United Kingdom Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Russia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Italy Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Asia-Pacific Generic Drugs Sales Market Share by Type (2016-2026)
Figure 71. Asia-Pacific Generic Drugs Sales Market Share by Application (2016-2026)
Figure 72. Asia-Pacific Generic Drugs Revenue Market Share by Region (2016-2026)
Figure 73. China Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Japan Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Korea Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. India Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Southeast Asia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Australia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South America Generic Drugs Sales Market Share by Type (2016-2026)
Figure 80. South America Generic Drugs Sales Market Share by Application (2016-2026)
Figure 81. South America Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 82. Brazil Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 83. Argentina Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 84. Middle East and Africa Generic Drugs Sales Market Share by Type (2016-2026)
Figure 85. Middle East and Africa Generic Drugs Sales Market Share by Application (2016-2026)
Figure 86. Middle East and Africa Generic Drugs Revenue Market Share by Country (2016-2026)
Figure 87. Turkey Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 88. Saudi Arabia Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 89. UAE Generic Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 90. Methodology
Figure 91. Research Process and Data Source

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs